The suppression of atherosclerosis, an important forerunner of acute ischemic cerebrovascular syndromes as well as diseases affecting other organs and vascular beds, provides further support for E-selectin tolerization as a promising strategy for prevention of stroke and other vascular diseases. This evidence concerns the gene SELE and Stroke.